Balversa Patient Brochure

Balversa (erdafitinib) is indicated for the treatment of advanced metastatic urothelial bladder cancer (mUC). Created 22 page, tabbed brochure to provide patients facing advanced mUC with accessible education about their FGFR status and the treatment option of Balversa. 

PRINT MOCKS-SITE-03.png
Patient Brochure_lv.25_CR_no draft_Page_
Patient Brochure_lv.25_CR_no draft_Page_
logo-balversa.png

*Additional pages available upon request.